IPD-1151T licensed to Yamanouchi for global development in cystitis and prostatitis Jan. 23, 2003 No Comments
E.U. approves Taxotere in combination with cisplatin for first-line NSCLC treatment Jan. 22, 2003 No Comments
RSS